Driving GxP strategies under the principles of Industry 4.0; enabling cost optimization while prioritizing innovation; bringing payers, providers, patients and policymakers in one value chain
The coronavirus pandemic has proved that advancing Industry 4.0 technologies have the potential for improving and saving millions of lives. Its applications go far beyond telemedicine. AI and other Industry 4.0 technologies are helping healthcare and health sciences companies ensure the safety of drugs by making the process counterfeit-proof while allowing the potential for customization and small-batch drug production. AI and ML together can collect and process multiple data points in the form of text and/or pictures to create accurate diagnostic tools and extend medical help to people and locations that do not have ready access to medical care.
Considering the critical nature of the sector, having an optimal digitalization strategy for Health Sciences is paramount. Capability analysis, planning, and prioritization are some of the most important aspects of digital transformation. With the right strategy in place, the industry has the potential to boost operational efficiency, reduce downtime, and improve profits.
Amplo Global offers a 4.0-led, cloud-based strategy simulation platform named AmploFly4.0™, helping health sciences’ leaders make informed decisions